High-Flow Nasal Oxygen and Noninvasive Ventilation for COVID-19 - 04/06/22
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Resumen |
High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) via facemask or helmet have been increasingly used in managing acute hypoxemic respiratory failure (AHRF) owing to COVID-19 with the premise of reducing the need for invasive mechanical ventilation and possibly mortality. Their use carries the risk of delaying intubation and nosocomial infection transmission. To date, most studies on the effectiveness of these modalities are observational and suggest that HFNO and NIV have a role in the management of AHRF owing to COVID-19. Trials are ongoing and are evaluating different aspects of noninvasive respiratory support in patients with AHRF owing to COVID-19.
El texto completo de este artículo está disponible en PDF.Keywords : COVID-19, Noninvasive ventilation, HFNO, Acute hypoxemic respiratory failure (AHRF)
Esquema
Vol 38 - N° 3
P. 601-621 - juillet 2022 Regresar al número
Artículo precedente
- Review of Anti-inflammatory and Antiviral Therapeutics for Hospitalized Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2
- Jen-Ting Chen, Marlies Ostermann
- Critical Care Response During the COVID-19 Pandemic
- Samuel Rednor, Lewis A. Eisen, J. Perren Cobb, Laura Evans, Craig M. Coopersmith
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.